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Baotgmu~t-Adm~slra!~ OI ~ s m  corNe~ng enzyme lACE) mhib~to~s 
in paftenl~ wire RI~OCaR~IJ m~a~O*l ~ repoRe0 to re~ the ,e~t~¢,~ of 
M~O0~: In a ~ ~b l ind .  ~ sludy begin- 
ning 4 w~ M1er m ~  mfarclmn, I !  I~P~",ts interred placebo (P 
group) and anolhe~ 11 mosNeO enalal~l lherelpy (E greup) fo~ 4,~meks Blood 
saml~ngs were pedom~m besom me sta,1 and on the 3m, 7th, and 28m days 
aftee ft~ strat d admmistrabon from an palmnls. ~e  measured ACE act~. 
~,, tissue facto~ (I"F) ant~jen levels and i~asmmog~,., ac~wato~ d~for  (PAt) 
/:~pR.~/ts" There wetre no ddference,z m ~ ACE 3c'tnnty (15.3 ± 1.7 and 
14_5± 12 IU.4), TF az, mgen leve~s (~30 ± 19at¢12~5 ~21 pg/ml) and PAl 
acidify (11.1 ± 0.Sand 10.6 ± 121UPmi) bet¢,~,'t t~e P~<IE  gre~p~ The 
ACE ~ (8_1 ± 1.2), TF antigen ~ (169 = 13) and PAl aCtWity (6.6 
± 1_3) deoeased on the 281h day m the E greup. However. ~vee vanables 
z~re u r ~  (15.2 ± 2.0. 247 ± 19. 115 ± 1.1) dunngme study penodin 
pat~mts receNed p~o~o.  
Conctustot~: Enalap~ therapy reduced the TF ant~jen leve~s And PAl 
ac~ m pat;~=nls w~'~ myocard~ infacbon_ The =mpro~=n~Ents m the coag- 
ulatmn and Ehe fdbnnoh~ system may be assoc~ted w~t~ ttte ~ in ~e 
esk ol comt~try ftwomf0os~s seen wdh ff~e use of ACE mhibrtor 
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Although ACE inhil~tors may reduo~ morlafdy in subacu~e myocardial infarc- 
tmn IM)) they could be harmful 0unng intetlse neurOhurnora| actnrabort In 
acute Mr. We mvesbgate~ ttte contnbut~on of ang~ofenstn-II (All) synthests 
inhibition, bradykmin (BK) break0own, and dosage Io the effects ol ACE In- 
hZbitors. Three hours after coronary I~atton or sham operahon, rats recofved 
the AT~-receptorbfocker Candesartan (Can. 4 mg/kg/d, n = 52), high or low 
dose Quinapril (Qui-hi. 50 mojkg/d, n = 56: Qui-to. 6 mg/kg/d, n = 52). BK-B.z 
receptor antagonist Hoe 140 (H. 500 pg/koJd, n = 76). H + Qui-h~ (n = 74). or 
Placebo (P. n = 51). After 7 days. mortality was anah/zed. In sz:nn~ng rats. 
left ventncular systolic (LVSP, mm Hg) and end<liastolic pressures (LVEDP. 
mm Hg) were measured by Mdlar catheter and left venfricular (LV) volume 
(Vol. ml/kg) was denved from passive pressure-volume relations. After MI. 
mortality with Can (13%). H (13%) H + Qui-hi (15%,) and Out-to (19%) was 
s~milar as wtth P (18%. p = n. s. ) but was higher wzth Qui-hi (38%. p < 005). In 
sham. mortality was zero with various treatments LVSP. LVEDP and Vol were 
reduced to similar levels with Qui-bi and Can but remained unchanged w~th 
Qui-lo, H and H + Qui-hi treatments. Table shows data of large MI (~.30% LV 
circumference): 
P Qut-h= Qul-lO Can H H + Oul-b= 
LVSP 104 ~ 3 87 ± 6 104 _+ 4 85 ± 4" 111 ± 3 l's 104 ± 3 ts 
LVEDP 15 ± 1 10 ± 2 12 ± 2 10 ± 1 15 ± 1 17 ± 1 t$ 
Vol 1.88±0.03 1.T4~:010 207±O105 1.62±O07 1.87±006 L90±O08 
(Mean ± SEM: "p ~ 0.05 vs. P, lp ~ 0.05 vs. Qui-h=, Sp • 0.05 vs. Can) 
Thus, the ATl-recoptorblocker is safe in acute MI and prevents eady re- 
modeling, whereas the ACE inhibitior is on,y effective at high dose which 
increases mortality in this model. 
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A H a ~ ,  M Fitched, A, Dahmen, J. SlandOll~ I , O. ~nt~.  
DeOan~t ot Ca~ogy, ~ ot ~,,m, Bonn, Ocnnany: 'Depanmen~ 
eac*grOur~ Du.ng c~m~ anest hamoconcenlrafmn d~lenorefes meo~ogy 
o! ~ ,  ca~ ~ phenomena a.d elfe(llvely impure .~c~x~a~mn 
Con.,~een~  eucces~ of hypersonic mine ~o~ (HS) ~rl resuscitation 
from t~ont~g~ shock we e~ume~ that H5 after car0mpuzmona~y rasus. 
c~talmn (CPR) n~ghl avoKl hemoc0nceffimbon, increase blood volume and 
~m~ove myocardial and cerebral blood flow (MBF, CBF). 
Me/ /~s :  In 30 arktesllletized ~ a 10 ~ m t ¢ c  cam~la¢ er, 
rest was lnduO~ by venfr~-,~laf fibnllallon, CPR was sta~d w~h apphcat~on of 
epme~'~-~ne, open chest cam~ massage and vsnttlatton. The ammals ran. 
a,..,~y receNed e*ther ?.5% NaCI or nom~al saline solution. 5 mmutu later 
DC-coume~ shock was appt~ to oetam return Of epomaneou= re~mulatmn 
(ROSC)- MBF and CBF were measured w~h Colored n'~crosphemS. ystem¢ 
hamody~an~ were ~ recont~. 
Resu/~: After HS infusmn hamatoont was s~gnircantty reduced dunng 
CPR artd tmtt~n me flnl130 minutes afll~ ROSC (43 ± 3 vs. 38 ± 3%), me 
paramofere myocardial (25 ± 12 Vs. 36 ± 18 mmHg) and cerebral pe~usmn 
pressure (32 ± 14 vs. 59 ± 13 mmHg), cardiac output (0.3 ± 01 vs. 0.6 ± 
0.2 1 n~n ~), MBF (1.5 ± 0.6 vs. 2.8 ± 1.8 ml g ~ mm ~) and CBF (0.5 ± 
02vs. 0.9 ±0.4mlg ~ mm~)wem ~gndmanttyimproved (p < 0.05). The2 
hour su~'wal rate for animal w~h HC Inft.,s;orl was =~lgnifica~ h~her lhan for 
controls (P < 003). 
~ '  The lmprovemerff of syslem~, myo~ard~l and c'erab~l ~r- 
cuJat~3n after HC infu~on dunng CPR after c:arct, ac arrest us correlated wrlh a 
t:~ler outcome. 
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Backgrot.g~ and Purpose: Manual sternal compression, ,=~s,Jered as lhe 
gold standard for external santoputmonary resusotat~on (CPR) is Of vanable 
e~c~=ncy. The automatic prmumat¢ chest vest (C.,ard~ic Systems Inc, 
Hanover. MD) pormds fatigue resistant, cncumferenfial chest compmssmn 
ME~?od: Mab'Iual ~ autonlal~c ~ l o n  were CCXllpare~ in ri~-H~Ew]3 
order in ~ bo~ne model (fl = 6. 65.3 -*- 6.5 kg) wTlh tugulo..camt¢l C~=¢¢,,JI- 
monary bypass (CPB) backup. Mean a~mai pressure (MAP) was measured 
through an mfrodzcer m the femoral artery and corona W flow velocity (CFV) 
was recorded with a 0.014 inch ~racorona W Ool~le~ wTre (Flowire, Cardk> 
metnCS. Mountain View, CA) posilioned in the LAD Animals were repeffused 
wlfh CF~ for 7 n'~n between CPR penoOs (3 n'~n) under vanous cond~t~ns of 
volen~a (extraco~'~feal blOOd storage m venous ~-von) .  Values (MAP & 
CBV) dunng CPR are expres~eQ as % of the values registered dunng CPB 
uno'er the same volemic condibons. 
Results: 
V~3cul~f voturr,~ MAP (mmHg) MAP (% of ~"P~) CF"V (¢nvs) CFV (% o! CPt3) 
hire CPB mare Jar vesl CPB manuel vest 
2 20~5 72 "= 215 122 : 41 15~I0 130 : 104 20~ z I~5 
1 5 19 *. 8 72 ~ 4 134 ~ 20 23 1:5 42 .~ 1B 100 ~ 14 
I 35=14 48 .* 13 ~CL6 ± 35 17±8 97"-58 137"-.57 
0 55=15 55:'10 88~36 23*--8 68+-36 119+=30 
+I 47=12 62~6 104¢20 25~8 62±26 113¢40 
Conclusions: Compared to external manual compression, automat.: pneu. 
malic vest CPR results in supenor, fatigue resistant systemic and coronary 
heamodynamics in the bovine model. 
